Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma

BACKGROUND: Anaplastic thyroid carcinoma (ATC) is a rare but deadly form of thyroid cancer. Kinase inhibitors kinase inhibitors have shown clinical efficacy in the management of ATC, however, eventually these tumors acquire resistance to KI and patients succumb to their disease. Salvage therapy in t...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:J Immunother Cancer
Główni autorzy: Iyer, Priyanka C., Dadu, Ramona, Gule-Monroe, Maria, Busaidy, Naifa L., Ferrarotto, Renata, Habra, Mouhammed Amir, Zafereo, Mark, Williams, Michelle D., Gunn, G. Brandon, Grosu, Horiana, Skinner, Heath D., Sturgis, Erich M., Gross, Neil, Cabanillas, Maria E.
Format: Artigo
Język:Inglês
Wydane: BioMed Central 2018
Hasła przedmiotowe:
Research Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6042271/
https://ncbi.nlm.nih.gov/pubmed/29996921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0378-y
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy